You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 99 No. 9, September 1981 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Dipivefrin and Echothiophate

Efficacy of Combined Use in Human Beings

Joel S. Mindel, MD, PhD; Michael E. Yablonski, MD, PhD; Henry O. Tavitian, MD; Steven M. Podos, MD; Juan Orellana, MD

Arch Ophthalmol. 1981;99(9):1583-1586.


Abstract

• In a previous study, pretreatment of rabbit eyes with echothiophate iodide prevented the ocular hypotensive effect of dipivefrin. The present masked study, using inpatient volunteers and nurse-administered drops, investigated whether a similar antagonism of action occurred in human beings. Eight volunteers received 0.25% echothiophate iodide twice a day in both eyes for three weeks. During the second week of therapy, one eye also received 0.25% dipivefrin twice a day and the contralateral eye received 2% epinephrine hydrochloride twice a day. During the third week of therapy, the eyes receiving dipivefrin and epinephrine were reversed. In four volunteers, dipivefrin plus echothiophate produced a significantly greater reduction in intraocular pressure than epinephrine plus echothiophate. As a group the eight eyes treated with dipivefrin plus echothiophate had significantly lower IOPs than the eyes treated with epinephrine plus echothiophate during the second week of therapy. Epinephrine plus echothiophate was never superior to dipivefrin plus echothiophate. Dipivefrin seemed to be effective during combination therapy with echothiophate.



Author Affiliations

From the Ophthalmology Section (Drs Mindel, Podos, and Orellana) and Psychiatry Department (Dr Tavitian), Bronx Veterans Administration Hospital; and the Departments of Ophthalmology (Drs Mindel, Yablonski, Podos, and Orellana) and Pharmacology (Dr Mindel), The Mount Sinai School of Medicine, New York.


Footnotes

Accepted for publication Nov 13, 1980.

Reprint requests to Department of Ophthalmology, Annenberg 22-14, The Mount Sinai School of Medicine, 1 Gustave L. Levy Pl, New York, NY 10029 (Dr Mindel).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effects of Echothiophate on Enzymatic Hydrolysis of Dipivefrin
Anderson et al.
Arch Ophthalmol 1984;102:913-916.
ABSTRACT  

Enzymatic and Nonenzymatic Hydrolysis of D,L-Dipivefrin
Mindel et al.
Arch Ophthalmol 1984;102:457-460.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.